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An extensive repertoire of molecular tools is available for genetic analysis in laboratory
strains of S. cerevisiae. Although this has widely contributed to the interpretation
of gene functionality within haploid laboratory isolates, the genetics of metabolism
in commercially-relevant polyploid yeast strains is still poorly understood. Genetic
engineering in industrial yeasts is undergoing major changes due to Clustered Regularly
Interspaced Short Palindromic Repeats (CRISPR) and CRISPR-associated protein (Cas)
engineering approaches. Here we apply the CRISPR/Cas9 system to two commercial
“starter” strains of S. cerevisiae (EC1118, AWRI796), eliminating the CAN1 arginine
permease pathway to generate strains with reduced urea production (18.5 and 35.5% for
EC1118 and AWRI796, respectively). In a wine-model environment based on two grape
musts obtained from Chardonnay and Cabernet Sauvignon cultivars, both S. cerevisiae
starter strains and CAN1 mutants completed the must fermentation in 8–12 days.
However, recombinant strains carrying the can1 mutation failed to produce urea,
suggesting that the genetic modification successfully impaired the arginine metabolism.
In conclusion, the reduction of urea production in a wine-model environment confirms
that the CRISPR/Cas9 system has been successfully established in S. cerevisiae wine
yeasts.
Keywords: CRISPR/Cas9 system, saccharomyces cerevisiae, wine, arginine degradation pathway, urea, ethyl
carbamate
INTRODUCTION
While for laboratory strains of Saccharomyces cerevisiae several molecular methods have allowed
extensive interpretation of gene functionality, industrial and wild yeast strains are still poorly
studied; indeed, the genetic manipulation of latter yeasts can be time consuming because of they
are usually recalcitrant to some molecular techniques and they are characterized by complex
genomes (i.e., diploid and polyploid species). For this reason, the development of a rapid and
efficient gene-targeting system based on the type II bacterial Clustered Regularly Interspaced Short
Palindromic Repeats and CRISPR associated protein (CRISPR-Cas9) system is gaining attention in
several industrial fields. Taking advantage of the high efficiency of homologous recombination (HR)
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in yeast, this system allows for double strand breaks and
simultaneous gene editing of all copies of the target sequence
(Gratz et al., 2013).
The CRISPR/Cas system, first discovered in Escherichia
coli, is present in many eubacteria and archaea where it can
provide resistance to bacteriophage or conjugative plasmids
(Barrangou et al., 2007; Hryhorowicz et al., 2017). Foreign
invading genetic material that is incorporated between CRISPR
repeat sequences is transcribed and processed into CRISPR RNAs
(crRNAs) that correspond to both foreign and CRISPR repeat
DNA. The crRNAs hybridize with transactivating CRISPR RNAs
(tracrRNAs) and the resulting crRNA/tracrRNA complex acts as
a guide for the endonuclease Cas9, which cleaves invading nucleic
acid sequences (Brouns, 2012; DiCarlo et al., 2013).
The main elements of the CRISPR/Cas9 system we used
are a bacterial CRISPR-associated protein nuclease (Cas9), from
Streptococcus pyogenes, and a short RNA guide. This latter
element combines with Cas9 to target a specific DNA locus
composed by 20 nucleotides and a NGG sequence, called
protospacer adjacent motif (PAM), where the cleavage occurs
in the nuclease domains RuvC and HNH (Mahfouz et al.,
2014). The gRNA-Cas9 complex generates DSBs immediately
before the PAM site on the target DNA (Ryan and Cate,
2014). Finally, the DSBs in the chromosomal DNA are repaired
with knockouts/deletions or knock-ins/insertion by NHEJ (non-
homologous end joining) and HR (homologous recombination)
(Gratz et al., 2013).
Aside from the molecular advantage of producing quick
genome changes by using a unique gene- editing approach, the
CRISPR/Cas9 system has the potential to soon become the gold
standard technique for the production of novel microorganisms
suitable for the food industry. The system produces marker-
free mutants and thus limits the environmental risk of using
genetically modified microorganisms. Indeed, the system has
been applied in many eukaryotic organisms (Komor et al., 2017)
such as mammalian cell lines (Lee et al., 2015), insects (Gratz
et al., 2013), and yeasts (DiCarlo et al., 2013; Ryan and Cate,
2014; Jakocˇiunas et al., 2015). It has also been applied in plants
where genetic modifications introduced by genome editing can
be indistinguishable from those introduced by conventional
breeding, such that the plants might be classified different
from traditional GMO (genetically modified organism) with
environmental risk equivalent to that of conventionally-bred
organisms (Bortesi and Fischer, 2015). Winemakers might also
benefit application of this new approach to grapes and to yeasts,
enabling better understanding of the connections between wine
features and wine yeast genetics.
In wine, urea is a major precursor of ethyl carbamate (EC), the
ethyl ester of carbamic acid (Weber and Sharypov, 2009). Urea is
the metabolic intermediate in the arginine degradation pathway
in S. cerevisiae, and accumulation of urea in wines generates
EC via a reaction between ethanol and the carbamyl group of
carbamic acid during wine storage. EC is found in fermented
foods such as grape wine, sake, distillated spirits, bread, kimchi,
yogurt (Lee, 2013). Stevens and Ough (1993) studied EC
formation under different storage condition; the EC is usually
found in significant amounts (0.01–0.025 mg/L) in wine and it
increases dramatically at high temperature with a logarithmic
increase when urea concentration decreases (Xue et al., 2015). EC
is a carcinogenic compound in a number of mammalian species
and it has been classified in March 2007 by the International
Agency for Research on Cancer (IARC) in group 2A (probably
carcinogenic to humans) from group 2B (possibly carcinogenic)
(Lee, 2013). Several countries have limitations of the amount of
EC in fermented food; for example, in Europe the determination
of EC in foods is under study by EFSA. The determination of
EC is difficult because of lack of physicochemical properties; gas
chromatography with mass spectrometry and high- performance
liquid chromatography with MS or FLD are methods for
EC determination (Lu et al., 2015). Two methods have been
developed for reducing EC levels in food; one is based on the
monitoring of all steps of the production chain starting from
the nitrogen fertilization of vineyards and the other one is based
on the use of controlled temperature during storage (Weber and
Sharypov, 2009). However, these two strategies are costly and
often unworkable for small-scale wine producers.
To the best of our knowledge, there are no studies available
that describe the use of the CRISPR/Cas9 approach in the
wine field. In this study, we adopt a strategy to modify wine
yeasts with the purpose of testing the robustness of this new
molecular tool and offering a new engineering pipeline for
further gene editing in specific metabolic pathways relevant for
wine production. In this study, two commercial S. cerevisiae
strains have been genetically engineered to eliminate the arginine
permease encoded by CAN1, leading to strains with reduced urea
production in laboratory and wine environments.
MATERIALS AND METHODS
Yeast Strains and Maintenance
Escherichia coli TOP10 served as plasmid host (Invitrogen, CA,
USA). For plasmid-selective growth, the TOP10 strain was grown
on LB [1% (w/v) Tryptone, 0.5% (w/v) Yeast Extract, 1% (w/v)
NaCl] and 100 µg/L ampicillin. For solid media 2% (w/v) agar
was included. Yeasts used in this work are two commercial wine
strains of S. cerevisiae: AWRI796 (Maurivin, South Africa) and
Lalvin EC1118 (Lallemand Inc, France). Cells were stored in YPD
medium (10 g/L yeast extract, 20 g/L peptone, 20 g/L glucose, 5.5
pH) supplemented with 20% (v/v) glycerol at −80◦C. Yeast pre-
cultures were produced by inoculating glycerol stocks at 1% (v/v)
in YPD broth at 30◦C for 3 days.
Drug Sensitivity Test by Spot Tests
Saccharomyces cerevisiae (AWRI796, EC1118) wine yeast
strains were tested for their sensitivity to Geneticin (G418),
Nourseothricin (Nat), Hygromycin B (Hyg), which is often
used for the selection of transformed cells and Canavanine
(Can), which is used, e.g., to select against diploid cells in the
Synthetic Genetic Array method (Tong and Boone, 2006). Since
possible interaction between drug and nitrogen source contained
in a medium can occur (Cheng et al., 2000), the capability of
strains to growth under the presence of G418, Nat, Hyg and
Can was tested in two types of media both based on YNB
without amino acids and ammonium sulfate (Sigma Aldrich,
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Germany) and 2% (w/v) glucose: (i) YNBA, contained 5 g/L
of ammonium sulfate, and (ii) YNBG was added with 1 g/L
of L-glutamic, as nitrogen sources. All drugs were prepared
as stock solution in distilled water, sterilized by filtration on
0.22µm filters and added to liquid or solid media after their
sterilization in autoclave. Yeast pre-cultures were obtained in
each medium after incubation in aerobic condition at 30◦C for
3–5 days. After OD600nm determination, yeast cultures were
diluted to 0.1 OD600nm in sterile water. Then, 1mL of culture
was centrifuged (10,000 g, 5min) and pellet was washed once
in 1mL of sterile water. Five µL of cells were spotted on Petri
dishes containing the corresponding solid media with 2% (w/v)
agar and supplemented with different concentration of drug.
In particular, cell sensitivity to antibiotics was assayed with: (i)
G418 at 0.2, 0.4, 0.6, 0.8 g/mL, (ii) Nat at 0.1, 0.2, 0.3 g/mL,
(iii) Hyg at 0.2, 0.4, 0.6, 0.8 g/mL, and (iv) Can at 0.1, 0.2, 0.4,
0.6 g/mL. Cellular growth was detected after 7 day at 30◦C.
Yeast growth in absence of any drug concentration was used
as positive control. Spot tests to determine the drug sensitivity
were carried out starting from two independent yeast cultures
and in duplicate. The full capability of the investigated strain to
grow under the tested condition was expressed by the sign “+”;
the symbol “−“ was assigned when no isolated colonies were
detectable; “±” indicated that a slight inhibition cell growth was
observed for single isolated colonies; the sign “−“ meant that
cells are sensitive to the tested concentration of drug.
DNA Manipulation
Plasmid DNA was prepared from E. coli (Sambrook et al.,
1989). All restriction reactions were carried out according to
manufacturer’s instruction (New England Biolabs, MA, USA).
PCRs were performed in a 25 µL reaction mixture composed
of Phusion 2x master mix (Invitrogen, Carlsbad, CA, USA),
10µM of forward and reverse primers and 80–100 ng DNA.
The amplification cycle was an initial denaturation at 95◦C
for 5min, 45 s at the annealing temperature (3◦C lower than
melting temperature) and 1.5min at 72◦C for the extension. Final
extension took 10min at 72◦C. Amplicons were separated on 1%
(w/v) agarose gel prepared in TBE buffer (0.09M Tris, 0.09M
Boric acid, 2mM EDTA) with 0.05 µg/L ethidium bromide
and bands were UV visualized (Geldoc 1000 System, Bio-Rad
Laboratories, California). Bands were extracted from gel, eluted
in 50 µL of mQ water using the QIAquick Gel Extraction Kit
(Qiagen, Hilden, Germany), and quantified by Qubit R© dsDNA
BR (Broad-Range) Assay Kits (Invitrogen). All ligation reactions
were performed using Rapid DNA Ligation Kit (Thermo Fisher
Scientific, MA, USA) according to operating instructions.
Yeast Transformations
The wine S. cerevisiae strains (AWRI796, EC1118) were subjected
to two sequential transformations. Each transformation was
completed in duplicate. For the first transformation, cells
were treated with a lithium/acetate protocol according to
the procedure described by Hill et al. (1991) and using 3
µg of transforming DNA. Recombinants were verified both
by growth assay and PCR-based detection of the kanMX6
cassette. To measure growth, the wild type yeasts and three
transformed clones of each S. cerevisiae strain were grown
in duplicate in YNBG medium supplemented with diff erent
concentrations of G418 (0, 200, 400, 800, 1,000, 1,200, 1,400,
1,800, and 2,000µg/mL) using a Tecan Genios plate-reading
spectrophotometer (Tecan, Germany). Specifically, fresh cell
cultures in YPD medium (aerobic condition, 30◦C, 24 h) were
used to inoculate 100 µL of YNBG medium at 0.1 OD 600 nm in
a 96-well plate. Cellular growth was monitored at 595 nm every
15min for a period of 24 h. For the PCR confirmation, DNA
was extracted by colony PCR protocol consisting in a treatment
of 5 µL of one full size colony dissolved in 200 µL ddH2O
with 20 µL of Zymolase lysis buffer [1 µL of 5 U/µL Zymolase
(Zymo Research, CA, USA) + 99 µL phosphate buffer] at 37◦C
for 2/3 h. After a step at 95◦C for 15min and centrifugation
at 2,000 rpm for 7min (Hettich Zentrifugen, Mikro 200), 3–5
µL of supernatant were used for the amplification with primers
GMX6_F and GMX6_R (Table 1).
The resulting G418-resistant transformed cells were exposed
to a second transformation by electroporation following the
method reported by DiCarlo et al. (2013) with few modifications.
Briefly, cells were grown in YNBG liquid medium supplemented
with 200µg/mL G418 at 30◦C up to stationary phase. Thus,
50 µL of pre-culture were inoculated in 100mL of the same
above medium and grown overnight. Cells have been collected
by centrifugation (18,000 g for 10min) between 0.7 and 1.5
OD600nm and re-suspended in 25mL of lithium/acetate buffer
(0.1M lithium acetate, 10mM DDT, 10mM Tris-HCl pH 7.5,
1mM EDTA pH 8) at room temperature for 1 h. Yeast cells were
then washed twice in 25mL of cold ddH2O and once in 10mL
of 1M cold sorbitol. After that, cells were pelleted 10,000 g for
15min at 4◦C and re-suspended in 100 µL of 1M cold sorbitol.
Each transformation treatment required 40µL of competent cells
and 10 µL of DNA containing 200 ng of vector expressing gRNA
corresponding to the CAN1 gene and the Nat resistance cassette,
and 2 µg of donor dsDNA (Table 1). The transforming mix was
kept on ice for 5min before electroporation at 2.5 kV, 25µF, 200
in 0.2 cm cuvettes (BioRad Micropulser, BioRad, CA, USA). One
mL of 1M cold sorbitol and YPD medium (1:1 ratio) was added
immediately after the current application and the cell suspension
was incubated at 30◦C for 3–6 h in static condition. Recombinant
clones were isolated first on selective plates of YNBG with
200µg/mL G418 and 50µg/mL Nat. Subsequently, cells were
replicated on YNBG plus 100µg/mL Can and transformants
were verified by: (i) targeting the Nat cassette using the colony
PCR protocol with Nat_F/Nat_R couple of primers (Table 1);
(ii) amplifying (CAN1_F/CAN1_R primers) and sequencing the
CAN1 gene by an external provider (TCAG, Toronto, CA).
The transformation efficiency was calculated as the number
of transformants generated per µg of supercoiled plasmid DNA
(Hayama et al., 2002). All data are calculated by applying
the algebraic average between the calculated transformation
efficiencies of each independent treatment. The mutation
efficiency was calculated as reported by Jakocˇiunas et al. (2015)
by picking 5 clones resistant to canavanine and submitting them
to Sanger sequencing, with the primer pair CAN1_F/CAN1_R,
to confirm the mutation in the expected position of the target
gene.
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TABLE 1 | Materials used in the present study.
Material Description References
STRAINS
E. coli TOP10 F−, mcrA ∆(mrr-hsdRMS-mcrBC) ϕ80lacZ∆M15 ∆lacX74 recA1 araD139
∆(ara-leu)7697 galU galK rpsL (StrR) endA1 nupG
Invitrogen (Carlsbad, CA, USA)
EC1118 S. cerevisiae Lalvin EC1118 Lallemand Inc, France
AWRI 796 S. cerevisiae AWRI 796 (Australian Wine Research Institute) Maurivin, South Africa
ScEC1118can1 S. cerevisiae EC1118 Gly70stop CAN1 (-GGC-→ -TAG-) This study
ScAWRI796can1 S. cerevisiae AWRI796 Gly70stop CAN1 (-GGC-→ -TAG-) This study
VECTORS
p414-TEF1p-Cas9-CYC1t CEN6/ARSH4 origin, TRP1, TEF1p promoter, codon optimized Cas9 with
C-terminal SV40 tag, AmpR
(DiCarlo et al., 2013); Addgene, USA
p426-SNR52p-gRNA.CAN1.Y-SUP4t 2µm ori, URA3, SNR52 promoter, gRNA CAN1.Y expression cassette, SUP
terminator, AmpR
(DiCarlo et al., 2013); Addgene, USA
p414-G418-TEF1p-Cas9-CYC1t CEN6/ARSH4 origin, kanMX6 cassette, TEF1p promoter, codon optimized
Cas9 with C-terminal SV40 tag, AmpR
This study
p426-Nat-SNR52p-gRNA.CAN1.Y-SUP4t 2µm ori, natMX6 cassette, SNR52 promoter, gRNA CAN1.Y expression
cassette, SUP terminator, AmpR
This study
pFA6a Extraction of the kanMX6 espression cassette (promoter and terminator TEF1) Bahler et al., 1998
P4339 Extraction of the natMX espression cassette (promoter and terminator TEF1) Tong and Boone, 2006
PRIMERS
Nat_F CGGCCGACATGGAGGCCCAGAATA (Tm = 78.4
◦C) This study
Nat_R CATATGCAGTATAGCGACCAGCATT (Tm = 65.7
◦C) This study
GMX6_F GGTACCCGACATGGAGGCCCAGAAT (Tm = 75.7
◦C) This study
GMX6_R TACGTACAGTATAGCGACCAGCATT (Tm = 59.7
◦C) This study
CAN1_F GACAAATTCAAAAGAAGACGCCGA(Tm = 66
◦C) This study
CAN1_R AAATATGATATAAGAGCGCCCACTG (Tm = 62
◦C) This study
gRN_F TGTAGTGCCCTCTTGGGCTA This study
gRNA_R TCGAGCGTCCCAAAACCTTC This study
CAN1.can1.Y.90.NCOD TTCACTTCAGCGTTCTGTACTTCTCCTTCATCTTCATCACCTATCTAATCCTC
CATAGAGAACGTATCCTCGCCATTTACTCTCGTCGGG
DiCarlo et al., 2013
CAN1.can1.Y.90.COD CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGGAGGATTAGATAGG
TGATGAAGATGAAGGAGAAGTACAGAACGCTGAAGTGAA
DiCarlo et al., 2013
Yeast Fermentations
Fermentation trials were carried out in synthetic and natural
grape musts. The composition of synthetic must grape was
obtained from the OIV protocol (Directive 22/06/2012,
Appendix I) with few modifications: 1.7 g/L YNB without amino
acids and ammonium sulfate (Sigma-Aldrich, Germany), 115 g/L
Glucose, 115 g/L Fructose, 5 g/L Tartaric acid, 3 g/L Malic acid,
0.2 g/L Citric acid, 2 g/L L-Arginine, pH 3.5. Two grape musts
produced in the Franciacorta area (Brescia, Italy) in vintage 2016
were used in this study: a red grape must of Cabernet Sauvignon
and a white grape must of Chardonnay. Sugar composition
of grape musts was: Cabernet Sauvignon 123.8 g/L Glucose,
123.2 g/L Fructose and for Chardonnay 93 g/L Glucose, 99 g/L
Fructose. The APA content of Cabernet Sauvignon was 47.35
mgN/L while Chardonnay contained 250 mg/L. To obtain a final
content of APA as 250 mg/L, the Cabernet Sauvignon grape
must was corrected with a 10 g/L Supervit solution (Enartis SC,
Novara) containing ammonium sulfate, ammonium phosphate
and thiamine. Two g/L of arginine were added before the cell
inoculation to each grape must (Amerine and Ough, 1980).
Both synthetic and natural grape musts were used to carry
out fermentation in flasks. Each strain was separately grown in
YPD broth in aerobic condition at 25◦C, overnight and then
it was inoculated in the synthetic grape must and in the grape
musts to obtain an initial cell concentration of about 2 × 106
UFC/mL. Fermentations were performed in triplicate in 250mL
glass flasks containing 200mL of medium. Fermentations in
laboratory conditions were performed in aerobic conditions at
25◦C while the ones in oenological conditions were run at 20 ±
2◦C. In order to establish a limiting oxygen condition as happens
in natural vinifications, flasks with grape must were capped with
Muller’s valves containing 12% (v/v) sulphuric acid. This enables
escape of carbon dioxide and avoids oxygenation of the musts.
While in synthetic must, yeast cell growth was monitored by
OD at 600 nm. In natural grape musts it was also determined by
CO2 loss through reduction of glass flask weight. At the end of
the alcoholic fermentation, when no weight variation is detected
for three consecutive days, wines were centrifuged at 18000 g for
5min and supernatants were maintained at −20◦C for further
chemical analyses.
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Chemical Determinations and Statistical
Analysis
The content of L-arginine/urea/ammonia, ethanol and sugars
(glucose/fructose) was determined by enzymatic kits (Megazyme,
Ireland) following manufacturer instructions. All data are
expressed by means of tree replications and standard deviation
(±SD). Nitrogen content in natural grape musts was assayed
by formol titration (Fracassetti and Tirelli, 2015). Urea yield
values were subjected to the one-way ANOVA in order to
infer the effect of strains (not-transformed and mutant yeasts);
statistically significant differences between means were defined
at p-value< 0.001.
RESULTS
The results presented here show the successful editing of
the CAN1 gene of two S. cerevisiae wine yeast strains using
a CRISPR/Cas9 system that consists of three elements: two
expression vectors carrying the Cas9 gene and the gRNA,
respectively, and a donor dsDNA fragment. To select the
most suitable selectable markers for plasmid construction, tests
were conducted to assess the sensitivity of the yeast strains
toward drugs generally used in genetic engineering trials.
After transformation, mutant strains were tested for their
capability of forming urea in synthetic and natural grape musts.
Fermentations in synthetic must, containing arginine as sole
nitrogen source, led to the quantification of the urea production
in wild type vs. mutant strains in absence of the nitrogen
catabolite repression. Whether experiments carried out in grape
must with several nitrogen sources allowed to validate the
actual contribution of the CAN1 gene in the urea production in
oenological conditions.
Drug Sensitivity of S. cerevisiae Wine
Strains
Saccharomyces cerevisiae EC1118 and AWRI796 strains had not
been previously analyzed for their resistance to common agents
commonly used for selectable markers. Therefore, assessment
of drug sensitivity was required to choose markers for vector
maintenance and recombinant yeast strains. Due to a possible
interaction between drug and nitrogen source contained in one
medium (Cheng et al., 2000), the capability of strains to growth
under the presence of G418, Nat, Hyg, and Can was tested
in YNBA and YNBG. All spot tests were run in duplicate.
All the tested yeast strains grew on both media without drug
supplementation in 3 days at 30◦C. After 7 days, differences in
the ability of forming colonies were observed among the analyzed
yeasts. Results showed that S. cerevisiae AWRI796 resulted more
sensitive than the EC1118 strain to canavanine (Table 2). A
higher drug sensitivity was detected when L-glutamic acid, rather
than ammonium sulfate, was added to the medium (Table 2). In
particular, this difference was observed in media with geneticin
and hygromycin B. Indeed, in presence of these two drugs both
strains grew up to a final concentration of 400µg/mL when
ammonium sulfate was added to the medium, while growth was
already inhibited at 200µg/ml in medium containing L-glutamic
acid. Based on these data, all transformations and fermentation
trials were carried out in YNBG medium (liquid or solid) and
G418 and Nat cassettes were chosen as selectable markers.
Construction of Plasmids
All recombinant strains, plasmids and primer pairs used
are listed in Table 1. The p414-G418-TEF1p-Cas9-CYC1t
and p426-Nat-SNR52p-gRNA.CAN1.Y-SUP4t plasmids were
obtained from p426-SNR52p-gRNA.CAN1.Y-SUP4t and p414-
TEF1p-Cas9-CYC1t vectors, respectively. In vector p414-TEF1p-
Cas9-CYC1t the TRP1 gene was removed and replaced with the
kanMX6 cassette (1365 bp), conferring resistance to G418. In the
vector p426-SNR52p-gRNA.CAN1.Y-SUP4t the URA3 gene was
substituted with the natMX cassette (1,126 bp) for the resistance
to Nat. The cassette conferring Nat resistance was amplified from
p4339 plasmid (Tong and Boone, 2006). The strategy used to
change the selective markers of the original plasmids was similar
for both new vectors. As a first step, TRP1 cassette was excised
from p414-TEF1p-Cas9-CYC1t using KpnI/SmaBI enzymes and
URA3 was removed from p426-SNR52p-gRNA.CAN1.Y-SUP4t
by digestion with EagI/NdeI enzymes. Compatible ends at
the 5′ and 3′ extremities of the kanMX6 and natMX
cassettes were generated by PCR amplification using primers
GMX6_F/GMX6_R and Nat_F/Nat_R, respectively. Finally, the
linearized plasmids and the corresponding resistance cassettes
were ligated in order to generate p414-G418-TEF1p-Cas9-CYC1t
(9,311 kb) and p426-Nat-SNR52p-gRNA.CAN1.Y-SUP4t (5,718
bp) plasmids (Figure 1).
Transformation Trials
During the first round of transformation, the plasmid p414-
G418-TEF1p-Cas9-CYC1t (containing the kanMX6 marker
for geneticin resistance) was transferred into cells using
the lithium/acetate protocol applied to about 108 cells per
transformation reaction. While a transformation efficiency of
about 222 ± 16 transformants per µg of DNA was calculated for
S. cerevisiae AWRI796, a considerably lower value was obtained
for S. cerevisiae EC1118 strain that showed a recovery of only
90 ± 6 transformants per µg of DNA. However, this difference
was not confirmed by subsequent PCR assay for presence of
the kanMX6 cassette; indeed, unlike what was observed for S.
cerevisiae EC1118 where all the analyzed clones produced the
expected fragment (1,365 bp), S. cerevisiae AWRI796 showed
that only one to three clones had been correctly transformed.
Finally, for each recombinant strain yielding positive PCR assay
for the selectable marker, two isolates were further inoculated in
liquid medium to assess G418 resistance. We found the kanMX6
cassette to confer resistance to the highest amount of antibiotic
tested (2 mg/mL) (Figure 2). Interestingly, both clones of S.
cerevisiae EC1118 showed the same growth fitness in YNBG,
unlike S. cerevisiae AWRI796 which grew more poorly than wild
type (data not shown).
For the second transformation by electroporation,
approximately 5 × 108 cells containing the plasmid p414-
G418-TEF1p-Cas9-CYC1t were co-transformed with the
vector p426-Nat-SNR52p-gRNA.CAN1.Y-SUP4t (containing
the natMX marker for nourseothricin resistance) and
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the donor dsDNA. Selection occurred in YNBG agar
medium supplemented with geneticin and nourseothricin.
A transformation efficiency of (5.50 ± 3.25) × 103 and (1.00
± 0.17) × 104 transformants for S. cerevisiae AWRI796
and EC1118 per µg of DNA was calculated, respectively.
In this case, the high transformation efficiency could be
linked to the time of cell recovery applied to electroporated
cells (3 h at 30◦C) before plating. Then, the recombinant
cells underwent a second canavanine selection on YPD agar
medium. Homologous recombination occurred with efficiency
of 32 ± 2 and 22 ± 4 transformants per µg of DNA for
S. cerevisiae AWRI796 and EC1118, respectively. The PCR
TABLE 2 | The first symbol on the left corresponds to the ability of growth in
YNBA and the symbol on the right refers to the yeast growth in YNBG medium.
Drug concentration
(µg/mL)
G418 Nat Hyg Can
0 +/+ +/+ +/+ +/+
50 nd/nd −/− nd/nd nd/nd
100 nd/nd −/− nd/nd AWRI796(−), EC1118 (±)/−
200 +/− −/− +/− −/−
300 nd/nd −/− nd/nd −/−
400 ±/− nd/nd +/− nd
600 −/− nd/nd −/− nd
800 −/− nd/nd −/− nd
G418, geneticin; Nat, nourseothricin; Hyg, Hygromycin B; Can, Canavanine. Cellular
growth is reported as: (+): full growth with no visible isolated colonies; (−): no cell growth;
(±): countable isolated colonies; nd: not determined. Spot tests were repeated twice.
amplification of the natMX cassette confirmed the presence
of the correct band at 1,126 bp from 10 selected clones per
strain. Sequence analysis of the CAN1 gene in the recombinant
strains showed the presence of a stop codon at the expected
position with a mutation efficiency of 100% of 5 isolates
(Figure 3).
Urea Production from Wild Type and can1
Mutant Strains
In a chemically defined medium with arginine as sole nitrogen
source, recombinant strains carrying the mutation in CAN1
gene showed a statistically significant decrease in urea yield of
18.5–35.5% for S. cerevisiae AWRI796 and EC1118, respectively
(Table 3). Indeed, a small amount of arginine was not consumed
by mutant cells [0.1 g/L for AWRI796can1 and 0.22 for
EC1118can1, as compared with the AWRI796 and EC1118
wildtype strains that exhausted the available arginine (2 g/L)].
Interestingly, S. cerevisiae AWRI796can1 showed a decrease in
the specific growth rate in comparison to its wild type (0.07 vs.
0.09 h−1 µmax) (Figure 4).
Must fermentations were carried out inoculating S. cerevisiae
AWRI796, AWRI796can1, EC1118 and EC1118can1 strains
in two grape musts obtained from Chardonnay (white) and
Cabernet Sauvignon (red) cultivars. The two wild type strains
completed the must fermentation in 8 days in both musts while
the two mutants ended their growth at the 12th and at the 9th
day in red in white musts, respectively (Figure 5). The biomass
production ranged from 2.23 to 3.02 g/L as an average for all
the tested strains, both wild and transformed; starting from the
same amount of sugars as for in synthetic must, the presence
FIGURE 1 | Representation of plasmid p414-G418-TEF1p-Cas9-CYC1t and p426-Nat-SNR52p-gRNA.CAN1.Y-SUP4t (SnapGene® Viewer 3.3.4).
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FIGURE 2 | Example of the ClustalΩ multiple sequence alignment. Partial amino acid sequence of CAN1 genes in wild type and recombinant strains: A8,
S. cerevisiae AWRI796can1 clone #8; A14, S. cerevisiae AWRI796can1 clone #14; E13, S. cerevisiae EC1118can1 clone #13; E15: S. cerevisiae EC1118can1 clone
#15; AWT, S. cerevisiae AWRI796, EWT, S. cerevisiae EC1118. A glycine amino amino residue (G = ggc) has been replaced by a STOP codon (− = tag) in position 70
from the methionine at the N-terminal of the protein.
of a complete pool of amino acids improved the cellular growth
(Table 3).
In both musts, although the wild type strain of S. cerevisiae
AWRI796 and EC1118 showed a better fermentative power
in comparison to the mutant strains (total grams of CO2
produced/volume of fermentation) (Figure 5), the ANOVA
highlighted that statistically significant differences were not
found among strains (Table 3). Comparing the two transformed
yeasts in terms of oenological traits, S. cerevisiae AWRIcan1 and
EC1118can1were most performant in red rather than white must
with a fermentative vigor (g CO2 produced in 48 h) of about
6.9 and 8.4 g, respectively. Although the mutant strains are able
to finish the fermentation in both white and red must, they
showed a delay of about 4 days; in terms of sustainability, this
behavior should be better investigated if strains are used in a real
oenological condition.
Finally, both can1 mutants failed to produce urea (Table 3)
and a lower consumption of arginine was detected in
fermentations carried out with the can1 mutant strains in
comparison to those with wild types (1.3 vs. 1.7 g/L).
DISCUSSION
Selected yeast starter strains are widely used because they possess
very good fermentative and oenological capabilities, contributing
to the standardization of fermentation process, wine quality and
safety. However, due to their polyploid nature, these strains are
still poorly characterized from a genetic point of view. Here we
outline a strategy to modify wine yeasts with the CRISPR/Cas9
system, an efficient, cheap and easy-to-use tool for genome
editing that allows the simultaneous modification of all the alleles
of a target gene. To prove the robustness of the CRISPR/Cas9
system in wine strains of S. cerevisiae and to provide a gene-
editing pipeline suitable for metabolic pathways relevant in wine
production, two commercial strains of S. cerevisiae (EC1118,
AWRI796) have been genetically engineered in CAN1 genes to
generate strains with a reduced urea production. The CAN1
gene, which encodes plasma membrane arginine permease, was
selected as a model gene for its dual significance: (i) it allows
the system validation by a negative selection of the transformed
clones using canavanine and (ii) it represents the first enzyme
of the arginine degradation pathway that is involved in the
production of urea, the main precursor of ethyl carbamate (EC),
a toxic compound (Ough et al., 1988).
Urea can be released by wine yeasts as the metabolic
intermediate from arginine breakage (Vincenzini et al., 2009).
According to this path, arginine is transported into the cell
through specific and/or general amino acid permeases (encoded
by CAN1 and GAP genes, respectively) and is cleaved by arginase
(CAR1 gene) into ornithine and urea. Urea can then be excreted
through Dur4p, a passive urea permease, or transformed by
Dur1p/Dur2p, two urea amidolyases, in ammonium and CO2.
Urea can undergo to a spontaneous, non-enzymatic, reaction
with ethanol forming EC, which is known to be genotoxic
and carcinogenic in a number of mammalian species and
which affects several fermented food products. The development
of techniques to prevent and/or reduce its content in wine
represents an important goal in wine industry. Genetically
modified yeasts in the genes of the arginine degradation pathway
have been already been obtained for sake and sherry wine
production (Coulon et al., 2006; Chiva et al., 2009; Dahabieh
et al., 2010; Wu et al., 2014; Zhao et al., 2014). However, no study
has investigated the role of CAN1 gene in the production of urea
in any fermentable source yielding human-consumed products.
By exploiting the CRISPR/Cas9 system, in the present work we
generated can1 mutants in S. cerevisiae wine strains in order to
investigate the urea production in oenological conditions. Prior
deciding how to construct useful vectors, yeasts were analyzed
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FIGURE 3 | Example of the growth kinetics of S. cerevisiae wild type strains (AWRI796 and EC1118) and recombinant clones (clone #23 and clone#8 for AWRI796
and EC1118, respectively) inoculated in YNBG liquid medium in duplicate under different concentrations of G418 (0, 200, 400, and 2,000µg/mL). Cellular proliferation
was monitored for 24 h, 30◦C using a Tecan microtitres reader (Tecan, Germany). The optical density was measured at 600 nm every 15min up to stationary phase.
Data are expressed by means of two replicates.
for their sensitivity to drugs commonly used in biotechnological
studies. For all the analyzed compounds, we observed different
levels of inhibition in the growth due mainly to the nitrogen
source present in the media as shown by Cheng et al. (2000) and,
only in the case of canavanine in rich medium, on the strain.
We also assessed the efficiency of each step in our sequential
transformation protocol. Low transformation efficiency was
observed for the vector expressing Cas9p. While a value of about
3–5 × 104 transformants/µg of plasmid DNA was expected
(Hill et al., 1991), an efficiency of two order of magnitude less
was calculated. Two possible hypotheses can be formulated;
first, the plasmid size was too large (9,311 bp for p414-G418-
TEF1p-Cas9-CYC1t) and reduced DNA uptake and/or Cas9p
expression yielded toxicity leading to cell death (Ryan and Cate,
2014). By contrast, the second transformation, mediated by
electroporation, yielded an efficiency similar to that reported in
literature (Gysler et al., 1990; Pribylova and Sychrova, 2003).
Finally, the CAN1 gene was successfully modified with a 100%
mutation frequency for both wine strains as shown by DiCarlo
et al. (2013) for a lab strain of S. cerevisiae.
The resulting phenotypes of the can1 mutants were evaluated
in a wine-model environment using laboratory and oenological
conditions. In a synthetic must, recombinant strains carrying
the mutation in CAN1 gene show a decrease in urea production
between 18.5 and 36.5%. This result can be due to presence
of the GAP1 gene, the general acid permease gene that
transports arginine into the cell (Chiva et al., 2009). In fact,
the GAP1 deletion could further reduce urea production (Wu
et al., 2014) but it might also further reduce specific growth
rate due to a reduced intake of arginine and other amino
acids into the cells. In this study, possibly because of the
metabolic modification of CAN1 gene, a variation of the specific
growth rate was observed in S. cerevisiae AWRI796can1 in
comparison to its wild type (0.07 vs. 0.09 h−1 µmax). Can1p
inactivation may have an effect on the specific growth rate due
to a reduced arginine uptake; however, further physiological
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AWRI796 AWRI796can1 EC1118 EC1118can1
Synthetic must
Urea (g/L) 0.190 ± 0.008 0.150 ± 0.015 0.120 ± 0.005 0.080 ± 0.004
Biomass (g/L) 2.30 ± 0.20 2.35 ± 0.05 1.92 ± 0.18 2.10 ± 0.25





22.1 ± 0.7 20.6 ± 0.6 22.0 ± 0.9 20.4 ± 0.3
Urea (g/L) 0.05 ± 0.002 n.d. 0.04 ± 0.002 n.d.
Biomass (g/L) 3.02 ± 0.08 2.23 ± 0.13 2.52 ± 0.075 2.38 ± 0.19





17.1 ± 0.5 16.1 ± 0.5 17.5 ± 0.5 17.0 ± 0.5
Urea (g/L) 0.020 ± 0.001 n.d. 0.01 ± 0.001 n.d.
Biomass (g/L) 2.55 ± 0.07 2.38 ± 0.13 2.50 ± 0.08 2.52 ± 0.02
Urea yield 0.008a 0b 0.004a 0b
Yields were calculated at the maximum level of biomass (g/L). The standard error of
enzymatic assays is calculated at 3%. The entry n.d = not detected (<0.13 mg/L,
according to the detection limit of the enzymatic kit). The ANOVA was applied to urea
yields calculated from fermentations performed in synthetic must and natural musts (red
and white), respectively. Mean values, on the same line, showing statistically significant
differences (p-value<0.001) are superscripted with different letters.
FIGURE 4 | Kinetics of growth of wild types and recombinant strains in
synthetic must. Data are expressed by means of three replicates and standard
deviation (±SD).
experiments should be carried out to verify this metabolic
behavior.
Since arginine is the most common organic nitrogenous
compound in grape juice, the growth rate and the biomass
production in can1 mutant strains could be more affected
than the wild type. In a wine-model environment, consisting
of two grape musts obtained from Chardonnay and Cabernet
Sauvignon cultivars, all the analyzed yeasts completed the must
fermentation. The most important result is that recombinant
FIGURE 5 | Production of CO2 by S. cerevisiae wild type (AWRI796 and
EC1118) and recombinant strains (AWRI796can1 and EC1118can1) in
oenological conditions. R, Cabernet Sauvignon must; W, Chardonnay must.
Data are expressed by means of three replicates and standard deviation (±SD).
strains, carrying only a mutation in the CAN1 gene, show
a complete reduction of urea in both musts. Of course, this
achievement has yet to be confirmed in other musts and under
actual winemaking conditions. Yeast can sense the numerous
available nitrogen sources in a medium and “tune” nitrogen
catabolite repression toward optimal utilization of nitrogen. In
a grape must, the presence of ammonia, a yeast could down-
regulate a pathway necessary to import arginine or other amino
acids. Therefore, rather than changing other enzymes of the
arginine degradation pathway with possible consequences on the
yeast fitness, the sole mutation in CAN1 could be enough to
reduce the urea production.
In conclusion, this study demonstrates that CRISPR/Cas9
system can be successfully established in S. cerevisiae wine yeasts,
and the editing of the CAN1 gene thereby yields a reduction of
urea production.
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